Alere $241.5 million acquisition of Epocal

Posted on 07 February 2013

Tags: ,

Alere's recent acquisition of Epocal, a provider of best-in-class technologies that support blood gas and electrolyte testing at the point of care.

After working capital and other adjustments made at closing, Alere paid approximately $166 million cash in the acquisition of Epocal, which includes a $15 million payment for the achievement of the first two financial milestones specified in the agreement.

Additional payments of up to $75.5 million could be triggered if milestones linked to the delivery of additional product offerings on the Epocal platform are achieved.

For further deal information visit Current Agreements (subscription required)

Related items:

Report: Merger and Acquisition Terms and Agreements

View: Current Partnering’s M&A Scorecardview top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more


Print Friendly, PDF & Email

Leave a Reply